Home / Data / Recall & Adverse Event Monitor Recall & Adverse Event Monitor Recall & Adverse Event Monitor organizes records from openFDA API into a static ledger for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 2,000
Last changed 08/30/2026
Update schedule 28 2 * * 4 UTC
Coverage 06/30/2026–06/30/2026 2026-06-30
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title APREMILAST
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title NEXPLANON
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title CARBOPLATIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DAYBUE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TALVEY
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TYMLOS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ATTRUBY
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title NUPLAZID
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title NUPLAZID
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title JASCAYD
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title NUPLAZID
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title NUPLAZID
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title HYDROCHLOROTHIAZIDE\LOSARTAN POTASSIUM
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title LACTULOSE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title GLATIRAMER ACETATE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DENOSUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OZEMPIC
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OZEMPIC
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OZEMPIC
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title RITUXIMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title IMBRUVICA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title NEMLUVIO
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title OZEMPIC
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title VEDOLIZUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TEDUGLUTIDE
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title NEUPRO
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title RINVOQ
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title DARATUMUMAB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title VYALEV
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title SKYRIZI
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ACALABRUTINIB
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title VENCLEXTA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title ELIGARD
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title RINVOQ
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title SYNTHROID
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title LINZESS
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title TRIPTORELIN
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24
Title FOSCARBIDOPA\FOSLEVODOPA
Record Date 06/30/2026
Event Classification source-event
Age Or Deadline Days 61.24 Source U.S. Food and Drug Administration, openFDA API · official record · retrieved 08/30/2026 · upstream last modified 08/30/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. Food and Drug Administration
Required notice Reports do not prove causation and are not medical advice, diagnosis, or an assessment of individual risk. What we add We compute Event Classification, Age Or Deadline Days, Public Significance Score using the documented compute method. · methodology